share_log

Needham Reiterates Buy on Clearside Biomedical, Maintains $4 Price Target

Needham Reiterates Buy on Clearside Biomedical, Maintains $4 Price Target

Needham 重申買入 Clearside Biomedical,維持4美元的目標股價
Moomoo 24/7 ·  03/13 06:29

Needham analyst Serge Belanger reiterates Clearside Biomedical (NASDAQ:CLSD) with a Buy and maintains $4 price target.

Needham分析師塞爾吉·貝蘭格重申了Clearside Biomedical(納斯達克股票代碼:CLSD)的買入,並維持4美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論